Induced Pluripotent Stem Cells Production Market Report, 2032

Induced Pluripotent Stem Cells Production Market - By Process (Manual, Automated), Product & Service (Consumables & Kits, Instruments, Service), Application (Drug Development & Discovery, Regenerative Medicine), End-use, & Global Forecast, 2024-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast calculation

1.4&nbsp;&nbsp;&nbsp; Data validation

1.5&nbsp;&nbsp;&nbsp; Data sources

1.5.1&nbsp;&nbsp;&nbsp; Primary

1.5.2&nbsp;&nbsp;&nbsp; Secondary

1.5.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.5.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Induced pluripotent stem cells production industry 3600&nbsp;synopsis, 2018 &ndash; 2032 (USD Million)

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Process trends

2.1.4&nbsp;&nbsp;&nbsp; Product &amp; service trends

2.1.5&nbsp;&nbsp;&nbsp; Application trends

2.1.6&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Induced Pluripotent Stem Cells Production Market Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032 (USD Million)

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising incidence of cancer

3.2.1.2&nbsp;&nbsp;&nbsp;Significant therapeutic potential of iPSC

3.2.1.3&nbsp;&nbsp;&nbsp;Increased applications in drug discovery &amp; development

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory requirements

3.2.2.2&nbsp;&nbsp;&nbsp;High production cost

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By process

3.3.2&nbsp;&nbsp;&nbsp; By product &amp; services

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2023

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2023

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2023

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard, 2023

Chapter 5&nbsp;&nbsp;&nbsp;Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Process, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by process

5.2&nbsp;&nbsp;&nbsp; Manual iPSC production process

5.3&nbsp;&nbsp;&nbsp; Automated iPSC production process

Chapter 6&nbsp;&nbsp;&nbsp;Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Product &amp; Service, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by product &amp; service

6.2&nbsp;&nbsp;&nbsp; Products

6.2.1&nbsp;&nbsp;&nbsp; Consumables &amp; kits

6.2.2&nbsp;&nbsp;&nbsp; Instruments/ devices

6.2.3&nbsp;&nbsp;&nbsp; Automated platforms

6.3&nbsp;&nbsp;&nbsp; Service

Chapter 7&nbsp;&nbsp;&nbsp;Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by application

7.2&nbsp;&nbsp;&nbsp; Drug development &amp; discovery

7.3&nbsp;&nbsp;&nbsp; Regenerative medicine

7.4&nbsp;&nbsp;&nbsp; Toxicology studies

7.5&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

8.2&nbsp;&nbsp;&nbsp; Pharmaceutical &amp; biotechnology companies

8.3&nbsp;&nbsp;&nbsp; Research &amp; academic institutes

8.4&nbsp;&nbsp;&nbsp; Contract research organizations

Chapter 9&nbsp;&nbsp;&nbsp;Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Lonza

10.2&nbsp;&nbsp;&nbsp; Axol Biosciences Ltd.

10.3&nbsp;&nbsp;&nbsp; Evotec SE

10.4&nbsp;&nbsp;&nbsp; Hitachi Ltd.

10.5&nbsp;&nbsp;&nbsp; Merck KGaA

10.6&nbsp;&nbsp;&nbsp; REPROCELLS, Inc.

10.7&nbsp;&nbsp;&nbsp; Fate Therapeutics

10.8&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

10.9&nbsp;&nbsp;&nbsp; StemCellsFactory III

10.10&nbsp;&nbsp;&nbsp; Applied StemCells, Inc.

10.11&nbsp;&nbsp;&nbsp; Creative Biolabs

10.12&nbsp;&nbsp;&nbsp; Bio-Techne Corporation 
&nbsp;

Induced Pluripotent Stem Cells Production Market

Get a free sample of this report